ICON completes ClinicalRM acquisition

By Melissa Fassbender

- Last updated on GMT

Icon’s acquisition of Clinical Research Management (ClinicalRM) expands its presence in the government sponsored research market. (Image: iStock/BernardaSv)
Icon’s acquisition of Clinical Research Management (ClinicalRM) expands its presence in the government sponsored research market. (Image: iStock/BernardaSv)

Related tags Vaccine

The acquisition, which was announced in June of this year, has been completed, expanding the company’s reach into government sponsored research.

As Outsourcing-Pharma.com previously reported​, the acquisition of Clinical Research Management, Inc. (ClinicalRM) expands Icon’s presence in the government sponsored research market.

The announcement secures a new line of customers for the company and extends its capabilities in the areas of vaccines and infectious disease.

Commenting on the completed acquisition, ICON’s CEO, Ciaran Murray said, “ClinicalRM has a strong track record of partnering successfully with government agencies and NGOs​.”

Murray added that the company will provide a platform for Icon to further penetrate this market segment as the company works to grow and diversify its customer base.

ClinicalRM’s work in the area of global vaccine development will further enhance our capabilities in this important area to the benefit of customers and patients globally​,” he said in the company's press release published this morning.

Icon did not respond to a request for additional comment.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Webinars

Headlines